News

Grading Dysplastic Nevi: Easy as Present or Not


 

SAN DIEGO — There's no need to grade the level of architectural disorder when assessing dysplastic nevi. Just acknowledge if it's present or not.

"It doesn't matter how much architectural disorder is there; it only matters that it's present or absent," Dr. Terry L. Barrett said at an update on melanoma sponsored by the Scripps Clinic. "It's like being pregnant. Every single person in the world can be divided into one of two categories: You're either pregnant or you're not."

His minimal criterion for defining the presence of architectural disorder in a lesion is a well-defined junctional nevus with nests at the base of the rete and lentiginous proliferation. Concentric eosinophilic fibroplasia and lamellar fibroplasia are commonly seen.

In addition to architectural disorder, dysplastic nevi may or may not have cytologic atypia, which may include large nuclei with variation of nuclear size; irregular nuclear membrane; variably staining chromatin; large eosinophilic nucleoli; and fine dusty melanin pigment in cytoplasm.

Some experts recommend that cytologic atypia be graded as mild, moderate, or severe, but Dr. Barrett does not use the term moderate. "If there's none there's none, but if there's some cytologic atypia it's either mild or severe," said Dr. Barrett of the departments of pathology and dermatology at the University of Texas, Dallas.

He favors a modified version of Dr. Arthur R. Rhodes' atypia grading system (Mod. Pathol. 1989;2:306–19). Cytologic atypia is considered mild if the size of the nucleus of the melanocyte is 1.5–2 times the size of the nucleus of the keratinocyte and if nucleoli are not present; if they are present, there should be no more than one per cell, he explained.

"I can tell that in 2 microseconds," Dr. Barrett said. "It's very easy."

Cytologic atypia is severe if there are multiple nucleoli per cell, or if the nucleus is more than two times the size of the basal keratinocyte nucleus, or if there is chromatin clumping or nuclear membrane notching.

"I can tell that very quickly," said Dr. Barrett, who also directs an outpatient pathology group in Dallas.

"More importantly, it's reproducible. I'll grant you that it's arbitrary. But the important thing is, no matter which one of the dermatopathologists who works with me signs this case out, it's going to be the same. For the dermatologist who gets the report, it's always going to be the same. If they ask me to review the case later because they want to know what I think, it's going to be the same because it's easy to do and it's reproducible."

Common acquired nevi begin to appear in childhood and increase in number from approximately 6 months of age until the third decade. At that point, they begin to decline in number. "They usually stabilize at 3–5 mm and rarely develop in patients over age 40," said Dr. Barrett, who had no relevant conflicts of interest to disclose.

In contrast, dysplastic nevi begin to appear near puberty and continue to develop throughout adulthood. "If you do serial photography of these lesions, they will increase and decrease in atypicality," he said. "They are usually greater than 5 mm."

Dysplastic nevi were originally classified as familial dysplastic nevi syndrome and sporadic nevus syndrome. Current concepts include the familial atypical mole/melanoma syndrome, which came out of the 1992 National Institutes of Health consensus statement on the diagnosis and treatment of early melanoma, and the abnormal mole phenotype. The latter definition was developed by researchers who proposed a spectrum approach that considers both the number and atypicality of nevi (West. J. Med. 1994;160:343–50). Melanoma risk increases along this continuum.

Initially, that theory "went nowhere because people didn't believe that you could have large numbers of common acquired nevi and no dysplastic nevi, and you [would nevertheless be] at increased risk for melanoma. But we now know that is absolutely true, and a number of studies have shown that patients who have large numbers of common acquired nevi have an increased risk of developing melanoma," Dr. Barrett said.

Melanoma risk also appears to increase in the presence of dysplastic nevi. A significant factor is the presence or absence of family history of either condition.

Intermittent sun exposure correlates with the risk of developing malignant melanoma and with the risk of developing multiple nevi. "Whether melanoma arises from nevi or not is unclear, but it appears that the stimulus for formation of both is the same," he said.

The risk of melanoma in a patient who has "one dysplastic nevus and nothing else" is the about the same as someone who has red or blond hair. "Not everybody with red or blond hair is going to get melanoma, but they are at an increased risk," he said.

Pages

Recommended Reading

Skin Ca Risk Up in RA Patients on Biologics
MDedge Dermatology
Sirolimus Use for Kaposi Opens Door to Research
MDedge Dermatology
A Multitude of Initial Diagnoses Seen for Nail SCC
MDedge Dermatology
Intensity-Modulated Radiation Tx May Cause Less Acute Dermatitis
MDedge Dermatology
CO2 Laser an Effective Option for Actinic Cheilitis
MDedge Dermatology
Melanoma Stem Cells May Hold Treatment Key
MDedge Dermatology
Nodular BCC Recurrence High After Photodynamic Therapy
MDedge Dermatology
Atrophic Dermatofibrosarcoma Can be Tough Call
MDedge Dermatology
MAL-PDT Reveals Cosmetic Edge Over Excision in BCC
MDedge Dermatology
The Magic Words [editorial]
MDedge Dermatology